These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22183507)

  • 1. Transplantation in 2011: New agents, new ideas and new hope.
    Srinivas TR; Kaplan B
    Nat Rev Nephrol; 2011 Dec; 8(2):74-5. PubMed ID: 22183507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression Minimization and Avoidance Protocols: When Less Is Not More.
    Prashar R; Venkat KK
    Adv Chronic Kidney Dis; 2016 Sep; 23(5):295-300. PubMed ID: 27742383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on chemical pharmacotherapy options for the prevention of kidney transplant rejection with a focus on costimulation blockade.
    Kälble F; Schaier M; Schäfer S; Süsal C; Zeier M; Sommerer C; Morath C
    Expert Opin Pharmacother; 2017 Jun; 18(8):799-807. PubMed ID: 28460546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards graft-specific immune suppression: Gene therapy of the transplanted kidney.
    Sandovici M; Deelman LE; Benigni A; Henning RH
    Adv Drug Deliv Rev; 2010 Nov; 62(14):1358-68. PubMed ID: 20688115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of immunosuppressive minimization and tolerance strategies.
    Brouard S; Budde K
    Transpl Int; 2015 Aug; 28(8):889-90. PubMed ID: 26178312
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic basis of allograft rejection and immunosuppressive agents in intestinal transplantation.
    Vianna R
    Minerva Pediatr; 2009 Jun; 61(3):293-303. PubMed ID: 19461573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stromal cells in renal transplantation: opportunities and challenges.
    Casiraghi F; Perico N; Cortinovis M; Remuzzi G
    Nat Rev Nephrol; 2016 Apr; 12(4):241-53. PubMed ID: 26853275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Southwestern Internal Medicine Conference. New advances in immunosuppression therapy for renal transplantation.
    Vazquez MA
    Am J Med Sci; 1997 Dec; 314(6):415-35. PubMed ID: 9413350
    [No Abstract]   [Full Text] [Related]  

  • 9. Transplantation: new protocols and new worries.
    Grinyo JM
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):192-7. PubMed ID: 19237802
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of tolerance in a chronic rejection model.
    Tullius SG; Nieminen M; Bechstein WO; Jonas S; Rayes N; Qun Y; Volk HD; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1075-6. PubMed ID: 9636436
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of initial antigen-independent events on acute allograft rejection: inhibition by a soluble P-selectin ligand and low-dose cyclosporine in combination.
    Kusaka M; Nadeau KC; Takada M; Nagano H; Shaw GD; Tilney NL
    Transplant Proc; 1998 Jun; 30(4):1027-8. PubMed ID: 9636414
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunopharmacologic therapy in renal transplantation.
    Shoker AS
    Pharmacotherapy; 1996; 16(4):562-75. PubMed ID: 8840362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in immunosuppressive therapy for renal transplantation.
    Peddi VR; First MR
    Semin Dial; 2001; 14(3):218-22. PubMed ID: 11422929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in pharmacotherapy to treat kidney transplant rejection.
    Bamoulid J; Staeck O; Halleck F; Dürr M; Paliege A; Lachmann N; Brakemeier S; Liefeldt L; Budde K
    Expert Opin Pharmacother; 2015; 16(11):1627-48. PubMed ID: 26159444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing early de novo immunosuppression with sirolimus.
    Weir MR
    Transplant Proc; 2008 Dec; 40(10 Suppl):S29-31. PubMed ID: 19100903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolution and future of immunosuppression in renal transplantation.
    Goral S; Helderman JH
    Semin Nephrol; 1997 Jul; 17(4):364-72. PubMed ID: 9241720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of Mesenchymal Stem Cells in Kidney Transplantation: From Bench to Bedside.
    Saidi RF; Moghadasali R; Shekarchian S
    Iran J Kidney Dis; 2019 Jul; 13(4):213-224. PubMed ID: 31422386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive treatment options in renal transplantation.
    Ciancio G; Burke GW; Jorge D; Rosen A; Miller J
    Minerva Urol Nefrol; 2005 Sep; 57(3):141-9. PubMed ID: 15986013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical renal transplantation: where are we now, what are our key challenges?
    Chapman JR
    Transplant Proc; 2010 Nov; 42(9 Suppl):S3-6. PubMed ID: 21095448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of desensitization, transplantation, and allograft dysfunction.
    Magee C; Clarkson M; Rennke H
    Clin J Am Soc Nephrol; 2008 Sep; 3(5):1573-81. PubMed ID: 18667745
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.